Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ATP128 |
Synonyms | |
Therapy Description |
ATP128 is a chimeric protein vaccine that potentially modify antigen presentation of dendritic cells, leading to activation of immune response against tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ATP128 | ATP 128|ATP-128 | ATP128 is a chimeric protein vaccine that potentially modify antigen presentation of dendritic cells, leading to activation of immune response against tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04046445 | Phase Ib/II | ATP128 + Ezabenlimab ATP128 ATP128 + Ezabenlimab + VSV-GP128 | Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01) | Active, not recruiting | USA | DEU | CHE | BEL | 0 |